Role of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with acute pulmonary embolism

J Thromb Haemost. 2003 Mar;1(3):492-3. doi: 10.1046/j.1538-7836.2003.00112.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Biomarkers / blood
  • Blood Coagulation
  • Carboxypeptidase B2 / blood
  • Carboxypeptidase B2 / physiology*
  • Case-Control Studies
  • Fibrinolysis
  • Humans
  • Pulmonary Embolism / blood*
  • Pulmonary Embolism / diagnosis
  • Severity of Illness Index

Substances

  • Biomarkers
  • Carboxypeptidase B2